Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »
August 21, 2012

Top 10 Pharma Firms

Check out which companies made the list.

Top 10 Pharma Firms

These are the ten pharmaceutical companies pulling in the most dollars. [© Pavel Ignatov - Fotolia.com]

  • Below are Top 10 pharmaceutical companies based on market capitalization at the end of the second quarter 2012, and the year-ago quarter, calculated by multiplying the number of outstanding shares by the share price. U.S. companies generally report their numbers of outstanding shares in their 10-Q quarterly earnings filings with the Securities & Exchange Commission. Companies based outside the U.S. either disclose market cap directly, or their numbers of shares “in issue” or “in free issue” in half-year and full-year results disclosures.

    For all companies, closing share prices as of the dates of their outstanding-shares figures can be found through any of several free stock information websites. Figures of non-U.S. companies were converted from various currencies.

  • #10. AstraZeneca

    2012 Market Cap: $56.34 billion (6/30: 1.259 million shares * 6/29 price $44.75)

    2011 Market Cap: $68.40 billion (6/30: 1.366 million shares * 6/30 price $50.07)

    % Change: -17.6%

  • #9. Bristol-Myers Squibb

    2012 Market Cap: $60.36 billion (6/30: 1,679,022,076 shares * 6/29 price $35.95)

    2011 Market Cap: $49.40 billion (6/30: 1,705,666,684 shares * 6/30 price $28.96)

    % Change: 22.2%

  • #8. Sanofi1

    2012 Market Cap: $96.99 billion (6:30: 1,321,852,008 shares * 6/29 price €59.74 = €78,967,438,957.92)

    2011 Market Cap: $91.95 billion (€E74.865 billion)

    % Change: 4.7%

  • #7. Abbott Laboratories

    2012 Market Cap: $101.17 billion (6/30: 1,569,333,729 shares * 6/29 price $64.47)

    2011 Market Cap: $81.91 billion (6/30: 1,556,576,533 shares * 6/30 price $52.62)

    % Change: 23.5%

  • #6. GlaxoSmithKline2

    2012 Market Cap: $111.45 billion (4.91M shares *1,447p /100 & convert)

    2011 Market Cap: $105.37 billion (5.036M shares *1,334p /100 & convert)

    % Change: 5.8%

  • #5. Novartis3

    2012 Market Cap: $133.9 billion

    2011 Market Cap: $150.1 billion

    % Change: -10.8%

  • #4. Merck & Co.

    2012 Market Cap: $134.53 billion (7/31: 3,045,632,274 shares * price $44.17)

    2011 Market Cap: $105.15 billion (7/29: 3,080,796,992 shares * price $34.13)

    % Change: 27.9%

  • #3. Roche4

    2012 Market Cap: $142.94 billion (CHF: 139.737M)

    2011 Market Cap: $123.35 billion (CHF: 120.587M)

    % Change: 15.9%

  • #2. Pfizer

    2012 Market Cap: $181.21 billion (8/6: 7,469,483,622 shares * price $24.26)

    2011 Market Cap: $129.98 billion (8/8: 7,802,126,616 shares * price $16.66)

    % Change: 39.4%

  • #1. Johnson & Johnson

    2012 Market Cap: $191.67 billion (7/27: 2,757,041,143 shares * price $69.52)

    2011 Market Cap: $177.55 billion (7/29: 2,740,354,114 shares * price $64.79)

    % Change: 8.0%

  •  

    Leave a comment by clicking the “Comments” icon. We want to hear your thoughts!

Posted 8/22/2012 by Susan Light

It would be interesting to see the number of employess listed along with the market cap.

 

Related content